Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MHC class II expression in lung cancer.

Lung cancer (Amsterdam, Netherlands) - 1 Oct 2017

He Yayi, Rozeboom Leslie, Rivard Christopher J, Ellison Kim, Dziadziuszko Rafal, Yu Hui, Zhou Caicun, Hirsch Fred R

Abstract excerpt

BACKGROUND: Immunotherapy is an exciting development in lung cancer research. In this study we described major histocompatibility complex (MHC) Class II protein expression in lung cancer cell lines and patient tissues. METHODS: We studied MHC Class II (DP, DQ, DR) (CR3/43, Abcam) protein expression in 55 non-small cell lung cancer (NSCLC) cell lines, 42 small cell lung cancer (SCLC) cell lines and 278 lung cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Rearrangement

Share to Histocompatibility Antigens Class II

Share to Neoplasm Staging

Share to Protein-Tyrosine Kinases

Share to Proto-Oncogene Proteins

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 29191604
DOI: 10.1016/j.lungcan.2017.07.030

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

MHC class II expression in lung cancer.PMID 29191604Read ↗

Loss of HLA haplotype in lung cancer cell lines: implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer.Semantic proximity Read ↗

Unfavorable prognosis of patients with non-small cell lung carcinoma associated with HLA-A2.Semantic proximity Read ↗

MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells.Semantic proximity Read ↗

Identification of a New Cancer/Germline Gene,<i>KK-LC-1</i>, Encoding an Antigen Recognized by Autologous CTL Induced on Human Lung AdenocarcinomaSemantic proximity Read ↗

Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.Semantic proximity Read ↗

Analysis of HLA class I and II alleles regarding to lymph node and distant metastasis in patients with non-small cell lung cancer.Semantic proximity Read ↗

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancerSemantic proximity Read ↗

FOXP3 and TLR4 protein expression are correlated in non-small cell lung cancer: implications for tumor progression and escape.Semantic proximity Read ↗

Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.Semantic proximity Read ↗

Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.